Stevens–Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

Key Points

Key points are not available for this paper at this time.

Abstract

Glucocorticoids and cyclosporine may be tentatively recommended as the most promising immunomodulatory therapies for SJS/TEN, but these results should be investigated in future prospective controlled trials.

Mark Helpful

Bookmark

Relay

Mark Helpful

Bookmark

Relay

Cite This Study

Houschyar et al. (Thu,) studied this question.

synapsesocial.com/papers/69df2b71d85e58e37b7a198c https://doi.org/https://doi.org/10.12968/jowc.2021.30.12.1012

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme1993 · 1,618 citations
2STAPHYLOCOCCAL SCALDED SKIN SYNDROME2011 · 28 citations
3A meta-analysis of cyclosporine treatment for Stevens&ndash;Johnson syndrome/toxic epidermal necrolysis2018 · 87 citations
4Accuracy of SCORTEN to predict the prognosis of Stevens‐Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta‐analysis2019 · 51 citations
5Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology—Thirty Years of Progress but Still Much to Be Done2017 · 119 citations